• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Is Zoetis Inc. (NYSE: ZTS) Overvalued? Or Is It Worth Buying Now?

    1/7/25 4:15:00 PM ET
    $LKQ
    $ZTS
    Motor Vehicles
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $LKQ alert in real time by email

    TROY, Mich., Jan. 7, 2025 /PRNewswire/ -- Zoetis's recent report has investors wondering if the company's stock is overvalued. Or is it in the buy range? As such, the Editorial Advisory and Securities Review Committee of BetterInvesting Magazine considers Zoetis (NYSE:ZTS) as worthy of further study and has named Zoetis its "Stock to Study" for the March 2025 issue for investors' informational and educational use.

    The fundamental data is eye-opening; investors can view Zoetis's sales, earnings, pre-tax profit, return on equity, and more all on one page, courtesy of the National Association of Investors, at:  https://ssg.betterinvesting.org/trial/ssgplus/?ticker=ZTS.

    A full report on Zoetis will appear in the March 2025 issue of BetterInvesting Magazine. 

    The same issue of BetterInvesting Magazine will also include a fundamental review of LKQ Corp. (NASDAQ:LKQ) which the independent Editorial Advisory and Securities Review Committee believes is worthy of further study from an undervalued perspective. 

    Committee members are Daniel J. Boyle, CFA; Marisa Bradbury, CFA; Philip Keating, CFA; Walter J. Kirchberger, CFA; Anne Nichols, CFA; and Dan Rutter, CFA.

    Securities mentioned are for study and presented for educational purposes only. They are not to be considered as endorsed or recommended for purchase by NAIC/BetterInvesting. Investors should conduct their own review and analysis of any company of interest using the Stock Selection Guide before making an investment decision.

    About BetterInvesting:

    BetterInvesting™, a national 501(c)(3) nonprofit, investment education organization, has been empowering everyday Americans since 1951. Also known as the National Association of Investors™ (NAIC®), we have helped more than 5 million people from all walks of life learn how to improve their financial future. BetterInvesting provides unbiased, in-depth investing education and powerful online stock analysis tools to create successful lifelong investors. BetterInvesting staff, along with a dedicated community of volunteers across America, teach the organization's principles and time-tested methodology to individuals and investment clubs. For more information about BetterInvesting, please visit www.betterinvesting.org

    Follow us on LinkedIn, Instagram and Facebook.

    Contact: 877-275-6242

    Cision View original content:https://www.prnewswire.com/news-releases/is-zoetis-inc-nyse-zts-overvalued-or-is-it-worth-buying-now-302344973.html

    SOURCE National Association of Investors/BetterInvesting

    Get the next $LKQ alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LKQ
    $ZTS

    CompanyDatePrice TargetRatingAnalyst
    Zoetis Inc.
    $ZTS
    6/18/2025$160.00Buy → Hold
    Stifel
    Zoetis Inc.
    $ZTS
    12/2/2024$215.00Outperform
    Leerink Partners
    Zoetis Inc.
    $ZTS
    7/25/2024$220.00Buy
    BTIG Research
    Zoetis Inc.
    $ZTS
    1/12/2024$195.00 → $215.00Buy
    Stifel
    Zoetis Inc.
    $ZTS
    12/19/2023$230.00Buy
    Jefferies
    Zoetis Inc.
    $ZTS
    12/7/2023$237.00Outperform
    Exane BNP Paribas
    Zoetis Inc.
    $ZTS
    9/6/2023$230.00Buy
    HSBC Securities
    LKQ Corporation
    $LKQ
    7/13/2022$68.00Buy
    MKM Partners
    More analyst ratings